Patents by Inventor Erwann Loret

Erwann Loret has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8999350
    Abstract: The invention relates to a method of preventing or treating acquired immunodeficiency syndrome (AIDS) in a patient, wherein the patient is administered with a Tat protein comprising amino acid sequence SEQ ID NO: 1 or 2, or a variant thereof capable of stimulating an immune response against Tat proteins.
    Type: Grant
    Filed: April 22, 2009
    Date of Patent: April 7, 2015
    Assignee: Universite d'Aix-Marseille
    Inventor: Erwann Loret
  • Publication number: 20120121632
    Abstract: The invention relates to a method of preventing or treating acquired immunodeficiency syndrome (AIDS) in a patient, wherein the patient is administered with a Tat protein comprising amino acid sequence SEQ ID NO: 1 or 2, or a variant thereof capable of stimulating an immune response against Tat proteins.
    Type: Application
    Filed: April 22, 2009
    Publication date: May 17, 2012
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE DE LA MEDITERRANNEE
    Inventor: Erwann Loret
  • Publication number: 20110212118
    Abstract: The invention relates to a method of preventing or treating acquired immunodeficiency syndrome (AIDS) in a patient, wherein the patient is administered with a Tat protein comprising amino acid sequence SEQ ID NO: 1 or 2, or a variant thereof capable of stimulating an immune response against Tat proteins.
    Type: Application
    Filed: April 22, 2009
    Publication date: September 1, 2011
    Applicants: UNIVERSITE DE LA MEDITERRANNEE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventor: Erwann Loret
  • Patent number: 7087377
    Abstract: The invention relates to an anti HIV 1 vaccine comprising the entire or part of the Tat HIV 1 protein, in addition to the identification of said protein in individuals affected by HIV. The Tat protein is a protein of the HIV 1 Oyi variant.
    Type: Grant
    Filed: October 21, 2004
    Date of Patent: August 8, 2006
    Assignee: Centre National de la Recherche Scientifique
    Inventor: Erwann Loret
  • Publication number: 20050106161
    Abstract: The invention relates to an anti HIV 1 vaccine comprising the entire or part of the Tat HIV 1 protein, in addition to the identification of said protein in individuals affected by HIV. The Tat protein is a protein of the HIV1 Oyi variant.
    Type: Application
    Filed: October 21, 2004
    Publication date: May 19, 2005
    Inventor: Erwann Loret